Titanium surface vertical graphene coating with antibacterial and drug-loading functions as well as preparation method and application of titanium surface vertical graphene coating

By preparing a vertical graphene coating on the titanium surface and loading teripatide drug, combined with the near-infrared photothermal conversion effect, the problem of insufficient initial stability of titanium implants and slow bone binding in patients with osteoporosis is solved, and the problem of further development is achieved. Good soft tissue enclosure and bone binding reduce the rate of implant failure and the risk of inflammation.

CN118903555APending Publication Date: 2024-11-08SHANGHAI XUHUI DISTRICT DENTAL HOSPITAL (SHANGHAI XUHUI DISTRICT DENTAL DISEASE CONTROL & PREVENTION INSTITUTE) +1
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411004452.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-25
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Titanium implants are insufficient in the initial stability due to biological inertia in transplantation treatment, which is prone to infection and inflammation. Especially in patients with osteoporosis, the implant binding rate is slow and the stability is low, which increases the risk of treatment.

Method used

Prepare a vertical graphene coating on the titanium surface and load teriparatide drugs on it. The graphene coating is grown through plasma chemical vapor deposition technology, combining the near-infrared photothermal conversion effect to improve soft tissue sealing and osseobinding capabilities.

Benefits of technology

Vertical graphene coating significantly improves the effect of soft tissue sealing and osteoporosis patients with osteoporosis, has excellent antibacterial properties and drug release ability, reduces the rate of implant failure, and prevents inflammation through photothermal sterilization during the infection period.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903555A_ABST
    Figure CN118903555A_ABST
Patent Text Reader

Abstract

The invention discloses a titanium surface vertical graphene coating with antibacterial and drug-loading functions as well as a preparation method and application thereof, and the titanium surface vertical graphene coating is prepared by growing a coating on the titanium surface in situ by adopting a plasma enhanced chemical vapor deposition technology, heating, annealing and cooling. Then, dropwise adding a teriparatide hydrochloride solution on the surface of the graphene coating, and then, drying, so as to obtain the teriparatide hydrochloride graphene coating. The vertical graphene coating provided by the invention has a good photo-thermal conversion effect and has an active antibacterial effect under the irradiation of near-infrared light, the implant abutment developed by utilizing the vertical graphene coating can be used for treating periarthritis of implants, and a good soft tissue sealing effect is generated; and the implant developed by using the artificial bone can improve the bone combination rate of the implant under the condition of osteoporosis of a patient.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical materials, and in particular to a titanium surface vertical graphene coating with antibacterial and drug-carrying functions, and a preparation method and application thereof. Background Art

[0002] With the continuous development of oral implant technology, implant restoration has gradually become the preferred treatment option for patients with missing teeth. Implant restoration can restore the patient's chewing function to the maximum extent and has almost no foreign body sensation. It has been increasingly accepted and recognized by people. Among them, titanium implants are widely used due to their good biocompatibility and corrosion resistance. The excellent performance of titanium implants is due to the chemical stability of titanium and titanium oxide. When the implant is exposed to air, a titanium oxide layer will form on the surface of the implant. However, the biological inertness of the material also hinders the integration process of the implant with the body tissue.

[0003] The inability of implants to obtain sufficient initial stability is one of the reasons for early failure of implant treatment. Insufficient bonding strength between implants and tissues will affect the stability of implantation and may lead to infection around the implant and the establishment of an inflammatory process, and induce peri-implantitis. In addition, the occurrence of implant failure is also related to the patient's own disease. For example, osteoporotic patients have slow bone bonding and low stability, and face greater risks when undergoing implant treatment.

[0004] Graphene nanosheets are deposited and grown perpendicularly to the substrate surface to form vertical graphene films. Compared with horizontal graphene coatings, vertical graphene coatings have rich edge structures and larger specific surface areas, and have obvious advantages in photothermal response and drug loading. The preparation of vertical graphene coatings on titanium surfaces helps to achieve photothermal sterilization effects, promote tissue cell spreading, adhesion and soft tissue closure, and improve the implantation effect of implants under specific conditions by loading drugs. Summary of the invention

[0005] The purpose of the present invention is to reduce the failure rate of implants, improve the soft tissue sealing effect of implants, solve the actual needs of implant bone integration under special conditions such as osteoporosis, and provide a titanium surface vertical graphene coating with antibacterial and drug-carrying functions, as well as its preparation method and application.

[0006] A vertical graphene coating on a titanium surface with antibacterial and drug-carrying functions, which is a vertical graphene coating with teriparatide drug loaded on the surface.

[0007] The method for preparing the titanium surface vertical graphene coating with antibacterial and drug-carrying functions comprises the following steps:

[0008] (1) Remove oil stains and micro-nano structures on the surface of titanium metal after grinding and polishing;

[0009] (2) growing vertical graphene coatings on titanium surfaces using plasma chemical vapor deposition equipment;

[0010] (3) Loading teriparatide drug on the vertical graphene coating surface.

[0011] The step (1) is to grind and polish a pure titanium sheet of 10 mm×10 mm×1 mm in size using 400 mesh, 600 mesh, 800 mesh and 1000 mesh silicon carbide sandpaper in sequence, and then ultrasonically clean the sheet twice using alcohol and ultrapure water in sequence, each time for 5 minutes, and then dry it at room temperature.

[0012] The step (2) is to place the titanium sheet treated in step (1) in a plasma chemical vapor deposition device, heat it to 600-900°C at a heating rate of 1-20°C / min, then maintain the target temperature for 1-60min for annealing, then start a plasma enhancement device with a power of 1-500W to grow a graphene coating on the surface of the titanium sheet for 1-120min, and then cool it to room temperature in a vacuum state, during which a mixed gas of CH4, Ar and H2 is introduced.

[0013] Step (3) is to drip a teriparatide solution with a spreading concentration of 0.1 mg / mL to 10 mg / mL on the surface of the vertical graphene, place it on a shaker, set the temperature to 25 to 60° C. for 24 hours, and obtain a vertical graphene drug-loaded coating after film formation.

[0014] Preferably, in step (2), the heating stage is carried out from room temperature to 750° C. at a heating rate of 10° C. / min, the annealing stage is maintained for 10 min, and the graphene growth stage is maintained for 60 min.

[0015] Preferably, in step (2), a mixed gas of Ar and H2 is introduced during the heating stage and the annealing stage, and the flow ratio of Ar to H2 is set to 16:1; in the graphene growth stage, a mixed gas of Ar, H2 and CH4 is introduced, and the flow ratio of Ar, H2 and CH4 is set to 80:5:2.

[0016] Preferably, the power of the plasma enhancement device is set to 100W.

[0017] Preferably, the concentration of the teriparatide solution is 1 mg / mL and the temperature is set to 37°C.

[0018] The application of the titanium surface vertical graphene coating with antibacterial and drug-carrying functions in the preparation of an oral implant abutment with antibacterial and soft tissue sealing functions.

[0019] The application of the titanium surface vertical graphene coating with antibacterial and drug-carrying functions in the preparation of an implant with the function of promoting osteoporosis bone integration.

[0020] Compared with the prior art, the present invention has the following beneficial effects:

[0021] (1) The vertical graphene coating described in the present invention can promote the expression of soft tissue closure-related genes in human gingival fibroblasts and has a strong ability to promote soft tissue closure.

[0022] (2) The vertical graphene coating described in the present invention has a strong photothermal conversion ability and thermal stability for near-infrared light, and after being treated with near-infrared light, it has excellent photothermal antibacterial properties against Staphylococcus aureus.

[0023] (3) The vertical graphene coating described in the present invention has excellent hydrophilic properties, can promote the expression of osteogenic-related genes in bone marrow mesenchymal stem cells from osteoporotic rats, and has a strong ability to promote bone integration.

[0024] (4) The vertical graphene coating described in the present invention can produce a bactericidal effect by responding to near-infrared light during the infection treatment period. When applied to the implant abutment, it can promote soft tissue closure to prevent peri-implantitis.

[0025] (5) After being loaded with drugs, the vertical graphene coating described in the present invention can be used for implant surface modification to improve implant bone integration in patients with osteoporosis. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 The microscopic images of Ti, VG and TE@VG materials prepared in Example 1 under a scanning electron microscope indicate that a vertically distributed graphene nanosheet coating can be successfully prepared on the surface of the VG sample after treatment. After loading the teriparatide drug, the surface morphology of TE@VG does not change significantly compared with the VG surface.

[0027] Figure 2 XRD patterns of Ti, VG and TE@VG materials prepared in Example 1. Obvious Ti phase can be detected on the surface of each coating, and a small amount of TiC phase is detected on the surface of VG and TE@VG.

[0028] Figure 3 This is the full XPS spectrum of the Ti, VG and TE@VG materials prepared in Example 1, indicating that after teriparatide drug loading, the characteristic elements N and S of teriparatide drug were detected on the surface of TE@VG, indicating that teriparatide was successfully loaded on the material surface.

[0029] Figure 4 The surface water contact angles of Ti, VG and TE@VG materials prepared in Example 1 indicate that after vertical graphene is grown on the Ti surface, the surface water contact angle increases. After teriparatide is loaded, the water contact angle decreases significantly, and the hydrophilicity is enhanced.

[0030] Figure 5The relative release amount of teriparatide detected after the TE@VG material prepared in Example 1 was immersed in pure water for 1 to 24 h and 1 to 14 d, indicating that the teriparatide drug loaded on the surface of TE@VG can achieve sustained release over a long period of time.

[0031] Figure 6 The cell proliferation activity of human gingival fibroblasts cultured on the surface of Ti and VG materials prepared in Example 1 indicates that VG material has good biocompatibility.

[0032] Figure 7 The expression data of soft tissue closure-related genes of human gingival fibroblasts cultured on the surfaces of Ti and VG materials prepared in Example 1 indicate that VG material helps promote soft tissue closure.

[0033] Figure 8 The temperature change curves of the surfaces of the Ti and VG materials prepared in Example 1 in response to infrared radiation, as well as the antibacterial effects on Staphylococcus aureus with and without infrared radiation, indicate that the VG material has good photothermal conversion capability and has a good antibacterial effect after infrared irradiation.

[0034] Fig. 9 The expression of osteogenic-related genes in mesenchymal stem cells from osteoporotic rats cultured on the surfaces of Ti, VG and TE@VG materials prepared in Example 1 indicates that TE@VG materials can promote the expression of osteogenic genes in the cells. DETAILED DESCRIPTION

[0035] The present invention is further described below by the following embodiments. It should be understood that the following embodiments are only used to illustrate the present invention, but not to limit the present invention.

[0036] The present invention relates to a vertical graphene coating on a titanium surface with antibacterial and drug-carrying functions. The present invention uses medical titanium as a substrate, utilizes plasma enhanced chemical vapor deposition technology to construct a vertical graphene coating on its surface, and then loads teriparatide drugs to prepare a vertical graphene drug-carrying coating. The vertical graphene coating can respond to near-infrared light, has excellent photothermal conversion effect, and can effectively kill Staphylococcus aureus attached to the surface of the sample. The vertical graphene coating has good biocompatibility, can promote the expression of soft tissue closure-related genes in human gingival fibroblasts, and improve the soft tissue closure effect. After drug loading, the vertical graphene coating can promote the expression of osteogenic-related genes in bone marrow mesenchymal stem cells from osteoporotic rats, and has excellent hydrophilic properties, which is beneficial to improving the bone integration effect.

[0037] The method for preparing the titanium surface vertical graphene coating with antibacterial and drug-carrying functions specifically comprises the following steps:

[0038] (1) Removal of oil stains and micro-nano structures on the titanium metal surface after grinding and polishing: A 10 mm × 10 mm × 1 mm pure titanium sheet was ground and polished using 400 mesh, 600 mesh, 800 mesh, and 1000 mesh silicon carbide sandpaper in sequence, followed by ultrasonic cleaning twice with alcohol and ultrapure water, each for 5 min, and then dried at room temperature.

[0039] (2) Growing a vertical graphene coating on the titanium surface using a plasma chemical vapor deposition device: placing the titanium sheet treated in step (1) in a plasma chemical vapor deposition device, heating it to 600-900°C at a heating rate of 1-20°C / min, then maintaining the target temperature for 1-60min for annealing, then turning on a plasma enhancement device with a power of 1-500W to grow a graphene coating on the surface of the titanium sheet for 1-120min, and then cooling it to room temperature in a vacuum state, during which a mixture of CH4, Ar and H2 is introduced.

[0040] (3) Loading teriparatide drug on the surface of the vertical graphene coating: drip a teriparatide solution with a spreading concentration of 0.1 mg / mL to 10 mg / mL on the vertical graphene surface, place it on a shaker, set the temperature to 25 to 60° C. for 24 h, and obtain a vertical graphene drug-loaded coating after film formation.

[0041] The following further exemplifies the present invention in detail. It should be understood that the following examples are only used to further illustrate the present invention and cannot be construed as limiting the scope of the present invention. Some non-essential improvements and adjustments made by those skilled in the art based on the above content of the present invention all belong to the scope of the present invention. The specific process parameters of the following examples are only examples in a suitable range, and those skilled in the art can make selections within a suitable range through the description of this article, but are not limited to the specific numerical values ​​​​exemplified below. Unless otherwise defined or specified, all professional and scientific terms used herein have the same meaning as those familiar to those skilled in the art. In addition, any method and material similar or equal to the recorded content can be applied to the method of the present invention.

[0042] Example 1

[0043] A 10 mm × 10 mm × 1 mm pure titanium sheet was ground and polished using 400 mesh, 600 mesh, 800 mesh, and 1000 mesh silicon carbide sandpaper, and then ultrasonically cleaned twice with ethanol and deionized water, each for 5 minutes. The obtained sample was named Ti.

[0044] The Ti sheet was placed in a plasma chemical vapor deposition device to prepare a vertical graphene coating in situ. During the heating stage, the temperature was raised to 750°C at a heating rate of 10°C / min, during which a mixture of Ar (80sccm) and H2 (5sccm) was introduced. The temperature was then maintained at 750°C, and a mixture of Ar (80sccm) and H2 (5sccm) was continuously introduced for annealing. The plasma enhanced equipment was then turned on, the power was set to 100W, maintained for 60 minutes, and a mixture of CH4 (2sccm), H2 (5sccm) and Ar (80sccm) was introduced to grow graphene on the titanium surface. After the growth stage, the gas was stopped, the system was maintained in a vacuum state, and naturally cooled to room temperature. The resulting sample was named VG.

[0045] The VG sheet was placed in a 75% ethanol solution and shaken for 4 times (30 minutes each time), and then placed on a clean bench to dry naturally. A 1 mg / mL teriparatide solution was prepared, and 100 uL was dripped onto each VG sheet and placed on a shaker at 37°C for 24 hours. The resulting sample was named TE@VG.

[0046] like Figure 1 As shown, the surface of the polished Ti sheet is flat and smooth, and vertically distributed graphene nanosheets can be observed on the VG surface after graphene growth. The loading of teriparatide drug has no further effect on the surface morphology of the sample.

[0047] like Figure 2 As shown in the figure, XRD characteristic peaks attributed to Ti were observed on the surfaces of Ti, VG and TE@VG, and XRD characteristic peaks attributed to TiC were observed on the surfaces of VG and TE@VG. This may be because the C deposited on the surface of the sample under heat treatment conditions reacts with the Ti in the matrix.

[0048] like Figure 3 As shown, the characteristic elements N peak and S peak of teriparatide were detected on the TE@VG surface, indicating that teriparatide was successfully loaded on the TE@VG surface.

[0049] Example 2

[0050] Use a surface contact angle tester to test the water contact angle of each sample surface. After placing the sample on the stage, use a dropper to drip 1μL of ultrapure water onto the sample surface. After the droplet stabilizes, take a photo through the system to detect the contact angle value. Each group of samples is tested at three different locations, and the final contact angle value is the average of three data.

[0051] like Figure 4 As shown in the figure, after the graphene layer is grown on the VG surface, the water contact angle of the sample surface increases. After loading teriparatide, it is detected that the water contact angle of the TE@VG sample surface is significantly reduced and lower than that of the Ti sample, indicating that the vertical graphene drug-loaded coating has excellent hydrophilicity.

[0052] Example 3

[0053] The release of teriparatide from the surface of TE@VG samples was detected using a BCA kit. Three pieces of TE@VG samples were immersed in 3 mL of pure water solution and placed in a 37°C constant temperature oven. The solution was aspirated at 1 h, 6 h, 12 h, and 24 h, and the concentration and amount of teriparatide released were detected using the BCA kit.

[0054] Three pieces of TE@VG samples were immersed in 3 mL of pure aqueous solution and placed in a constant temperature oven at 37 °C. The solution was aspirated at 1d, 4d, 7d and 14d, and the release concentration and amount of teriparatide were detected using the BCA kit.

[0055] like Figure 5 As shown, the relative release amount of teriparatide from the surface of TE@VG samples in pure water was calculated. The teriparatide loaded on the surface of TE@VG samples can be quickly released by about 40% after immersion for 1 hour, and then gradually released to about 80% within 24 hours. A small amount of teriparatide release can still be detected within the 14-day immersion period.

[0056] Example 4

[0057] Use 0.50w / cm 2 , 808nm near-infrared light was used to irradiate the surface of Ti and VG samples, and the surface temperature changes of Ti and VG samples were detected and recorded.

[0058] The antibacterial properties of the sample surface were evaluated using the standard strain of Gram-positive Staphylococcus aureus (S. aureus, ATCC 25923). The bacteria in the logarithmic growth phase were diluted to 10 7 CFU / mL. After the samples were sterilized with 75% alcohol, they were placed in a 24-well plate, 60 μL of bacterial solution was added to each well, and the plates were cultured in a 37°C incubator. After 24 hours of culture, the Ti and VG samples were divided into two groups, and 1 mL of saline was added to each well. One group was treated with a power density of 0.5 w / cm 2 The 808nm near-infrared light was irradiated for 10 minutes, and the other group was not treated. The bacterial solution was collected and diluted in multiples. 100μL of the diluted bacterial solution was evenly spread on the surface of the agar plate, and the agar plate was inverted and placed in an incubator for 18 hours. The number of colonies on the surface of the agar plate was counted (GB / T4789.2), and the antibacterial rate of the sample was calculated: Antibacterial rate (%) = (AB) / A×100%, where A is the average number of colonies on the surface of the Ti sample, and B is the average number of colonies on the surface of the experimental group sample.

[0059] like Figure 6As shown in the figure, after 600s of near-infrared light irradiation, the surface temperature of the Ti sample was detected to rise to about 45°C, and the surface temperature of the VG sample was detected to rise to about 55°C. The VG sample has better photothermal conversion ability. The antibacterial experimental results show that under the condition of no infrared light, the VG sample has a certain antibacterial effect on Staphylococcus aureus, and the antibacterial rate is about 50%. This may be due to the physical structure of the vertical graphene grown on the surface of the sample affecting the adhesion and growth of bacteria. After near-infrared light irradiation, the amount of bacteria on the surface of the Ti sample was reduced to a certain extent, and the antibacterial effect of the VG sample was significantly improved to about 100%, which was attributed to the good photothermal conversion effect of the VG sample, which effectively killed the bacteria attached to the surface.

[0060] Example 5

[0061] AlamarBlue was used to detect cell proliferation on the sample surface. Ti, VG, and TE@VG samples were placed in a 24-well plate, and the density of human gingival fibroblasts seeded on the surface of the material was 2×10 4 After 1, 4, and 7 days of cell culture, the samples were placed in new 24-well plates, rinsed twice with PBS, and 500 μL of DMEM medium containing 10% AlamarBlue was added to each well. The plates were cultured in an incubator in the dark for 2 hours, and the fluorescence intensity of the culture medium was detected using a microplate reader (excitation wavelength 560 nm, emission wavelength 590 nm).

[0062] like Figure 7 As shown, during the 7-day culture period, the human gingival fibroblasts on the surface of the VG sample did not show a significant decrease in cell viability compared to Ti, indicating that the VG sample has good biocompatibility.

[0063] Example 6

[0064] Ti and VG samples were placed in a 24-well plate at 2 × 10 4 Human gingival fibroblasts were inoculated at a density of 10 cells / well, and the culture medium was DMEM culture medium containing 15% FBS. After culturing the cells for 2 days, the samples were placed in a new 6-well plate, and the cell RNA was extracted by blowing the sample surface with Trizol reagent.

[0065] Ti, VG and TE@VG samples were placed in a 24-well plate at 1×10 4 Mesenchymal stem cells of osteoporosis model rats were inoculated at a density of cells / well, and the culture medium was DMEM culture medium containing 15% FBS, and osteogenic induction agent was added. After 14 days of cell culture, the samples were placed in a new 6-well plate, and the surface of the samples was blown with Trizol reagent to extract cell RNA.

[0066] The extracted RNA was transcribed into cDNA using the Takara reverse transcription kit, and then the reaction system was configured using the Takara kit. The QuantStudio 1 instrument was used to perform qRT-PCR experiments to detect the expression levels of cell target genes.

[0067] like Figure 8 As shown, human gingival fibroblasts on the surface of VG samples significantly upregulated Fibronectin, COLⅠ, ACTA2 and TGF-β genes, indicating that VG samples can promote the expression of soft tissue closure-related genes in human gingival fibroblasts.

[0068] like Fig. 9 As shown, the bone marrow mesenchymal stem cells derived from osteoporotic rats on the surface of TE@VG samples significantly upregulated the expression of osteoblast-related genes such as SPP1, COLⅠ and ALP, indicating that TE@VG samples can promote the expression of bone marrow mesenchymal stem cells derived from osteoporotic rats and have a certain osteogenesis-promoting effect.

Claims

1. A vertical graphene coating on titanium surface with antibacterial and drug-carrying functions, characterized in that: Vertical graphene coating with teriparatide drug loaded on the surface.

2. A method for preparing a titanium surface vertical graphene coating with antibacterial and drug-carrying functions as claimed in claim 1, characterized in that: The following steps are involved: (1) Remove oil stains and micro-nano structures on the surface of titanium metal after grinding and polishing; (2) growing vertical graphene coatings on titanium surfaces using plasma chemical vapor deposition equipment; (3) Loading teriparatide drug on the vertical graphene coating surface.

3. The method for preparing a titanium surface vertical graphene coating with antibacterial and drug-carrying functions according to claim 2, characterized in that: The step (1) is to grind and polish a pure titanium sheet of 10 mm×10 mm×1 mm in size using 400 mesh, 600 mesh, 800 mesh and 1000 mesh silicon carbide sandpaper in sequence, and then ultrasonically clean the sheet twice using alcohol and ultrapure water in sequence, each time for 5 minutes, and then dry it at room temperature.

4. The method for preparing a titanium surface vertical graphene coating with antibacterial and drug-carrying functions according to claim 2, characterized in that: The step (2) is to place the titanium sheet treated in step (1) in a plasma chemical vapor deposition device, heat it to 600-900°C at a heating rate of 1-20°C / min, then maintain the target temperature for 1-60min for annealing, then start a plasma enhancement device with a power of 1-500W to grow a graphene coating on the surface of the titanium sheet for 1-120min, and then cool it to room temperature in a vacuum state, during which a mixed gas of CH4, Ar and H2 is introduced.

5. The method for preparing a titanium surface vertical graphene coating with antibacterial and drug-carrying functions according to claim 2, characterized in that: Step (3) is to drip a teriparatide solution with a spreading concentration of 0.1 mg / mL to 10 mg / mL on the surface of the vertical graphene, place it on a shaker, set the temperature to 25 to 60° C. for 24 hours, and obtain a vertical graphene drug-loaded coating after film formation.

6. The method for preparing a titanium surface vertical graphene coating with antibacterial and drug-carrying functions according to claim 4, characterized in that: In the step (2), the heating stage is heated from room temperature to 750° C. at a heating rate of 10° C. / min, the annealing stage is maintained for 10 min, and the graphene growth stage is maintained for 60 min.

7. The method for preparing a titanium surface vertical graphene coating with antibacterial and drug-carrying functions according to claim 4, characterized in that: In the step (2), a mixed gas of Ar and H2 is introduced during the heating stage and the annealing stage, and the flow ratio of Ar to H2 is set to 16:1; in the graphene growth stage, a mixed gas of Ar, H2 and CH4 is introduced, and the flow ratio of Ar, H2 and CH4 is set to 80:5:

2.

8. The method for preparing a titanium surface vertical graphene coating with antibacterial and drug-carrying functions according to claim 4, characterized in that: The power of the plasma enhancement device is set to 100W.

9. The method for preparing a titanium surface vertical graphene coating with antibacterial and drug-carrying functions according to claim 5, characterized in that: The concentration of the teriparatide solution was 1 mg / mL, and the temperature was set at 37°C.

10. A titanium surface vertical graphene coating with antibacterial and drug-carrying functions as claimed in claim 1, characterized in that: Application in the preparation of oral implant abutments with antibacterial and soft tissue sealing functions, and application in the preparation of implants with osteoporotic bone integration promotion functions.

Citation Information

Cited By

  • Network energy saving implementation using O1 interface

    CN122123033A